CN1679889A - Medicine for inhibiting and eliminating cancer - Google Patents

Medicine for inhibiting and eliminating cancer Download PDF

Info

Publication number
CN1679889A
CN1679889A CN 200510012306 CN200510012306A CN1679889A CN 1679889 A CN1679889 A CN 1679889A CN 200510012306 CN200510012306 CN 200510012306 CN 200510012306 A CN200510012306 A CN 200510012306A CN 1679889 A CN1679889 A CN 1679889A
Authority
CN
China
Prior art keywords
medicine
herba
cancer
radix
cordyceps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 200510012306
Other languages
Chinese (zh)
Other versions
CN1314409C (en
Inventor
谢志明
谢辉权
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB200510012306XA priority Critical patent/CN1314409C/en
Publication of CN1679889A publication Critical patent/CN1679889A/en
Application granted granted Critical
Publication of CN1314409C publication Critical patent/CN1314409C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

A Chinese medicine for suppressing and eliminating cancers is prepared from 16-20 Chinese-medicinal materials including notoginseng, astragalus root, human placenta, cordyceps, etc.

Description

A kind of medicine that suppresses and eliminate cancer
Technical field
The invention belongs to Chinese medicine, be specifically related to a kind of medicine that can suppress and eliminate cancer, particularly obvious for eliminating the cancer pain effect.
Background technology
Cancer is to cause one of human dead main disease.Some cancer can operative treatment, and for the inoperable Drug therapy that can only adopt, to prolong patient's life.The medicine that is used for the treatment of this class disease at present is a lot, can be divided into two classes substantially, and a class is a chemical synthetic drug, and a class is a compound Chinese medicinal preparation.The chemical synthetic drug side effect is bigger, and late result is not good, is difficult for taking for a long time, particularly requires careful usefulness for some gastroenteropathy patients or hepatic and kidney function obstacle person.
Cancer can cause various pain, and this has just aggravated patient's misery, particularly cancer of late stage, and the agents alleviate symptom that can only adopt some to relieve the pain for this class patient is to alleviate the degree of patient's pain.The analgesic that adopts mostly is Western medicine oral medicine or injection at present, and life-time service easily produces dependency to medicine.
Summary of the invention
The purpose of this invention is to provide a kind of medicine that can suppress and eliminate cancer.
Another object of the present invention is in to treatment of cancer, also can play mitigation to the pain that cancer causes.
The cancer that doctor trained in Western medicine is alleged is classified as the disease of " a gathering " class more in the traditional Chinese medical science.Theory of Chinese medical science is thought, the generation of primary disease, and how because of seven emotions pent-up, diet internal injury etc., exopathogen is invaded and the positive QI-insufficiency of body, causes to make liver spleen heart kidney impaired, and internal organs are become estranged, and QI and blood retardance, pent-up are given birth to for a long time and are pyretic toxicity, and expectorant is tied in the congestion and is stopped, and pathogenic factor is gradually long-pending to form; With the passing of time then sap one's vitality, pathogen is more contained, and the resistance pain day of becoming silted up is heavy, does not more have the power of driving away pathogenic factor.Suitable reinforcement and elimination in combination, strengthening vital QI to eliminate pathogenic factors in treatment are rule of treatment to train first QI invigorating, heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving.
If the present invention suppresses and the drug main of elimination cancer is prepared from by following materials of weight proportions medicine:
Radix Notoginseng 3-9g Radix Astragali 5-12g Herba Dracocephali 3-9g Herba Artemisiae Anomalae 3-9g Sargassum 5-15g
Thallus Laminariae (Thallus Eckloniae) 5-15g Fructus Psoraleae 5-15g Herba Selaginellae 3-9g Herba Lobeliae Chinensis 3-12g Flos Lonicerae 3-12g
Rhizoma Smilacis Glabrae 3-12g Hepar Bovis seu Bubali 6-20g Placenta Hominis 3-12g Cordyceps 3-8g Fructus Crataegi 3-9g
Very light blue 3-9g.
Can also add Radix Paeoniae Rubra 0-12g, Rhizoma Corydalis 0-15g, Olibanum 0-9g and Myrrha 0-9g in the said medicine.
Add Radix Paeoniae Rubra, Rhizoma Corydalis, Olibanum and Myrrha in the medicine, strengthen its promoting the circulation of QI and blood analgesic effect, more be adapted to executing of patient with advanced cancer and control.
Said medicine also can adopt local external application therapy, and medicine is ground to the powder altogether, makes pasty state, is applied to lump or sore place, and Zhou Jing is slightly larger than lump, and change dressings once every day.For oral administration executing simultaneously with local external application controlled.
The active component of said medicine can become pharmaceutical composition with pharmaceutically acceptable vehicle group, makes powder, tablet, granule, electuary, pill, capsule and oral liquid.
In the prescription of the present invention, the Radix Astragali is sweet in flavor and warm in property, goes into the spleen lung meridian, the gas of the big spleen reinforcing lung of energy, expelling pus and toxin by strengthening QI granulation promoting; Placenta Hominis sweet-salty temperature is gone into the cardiopulmonary kidney channel, QI invigorating, nourishes blood, mends essence, and strongly invigorating primordial QI is kindly controlled all deficient labor utmost points of men and women, and following unit is feeble and exhausted; The Cordyceps nature and flavor are sweet flat, go into the lung kidney channel, and the energy nourishing the lung and kidney is specially adapted to the deficient recovery of prolonged illness; The arduous temperature of Fructus Psoraleae flavor property is gone into the kidney spleen channel, can the kidney invigorating primordial qi strengthening.The above Radix Astragali, Placenta Hominis, Cordyceps, Fructus Psoraleae are all the tonification good merchantable brand, are combined as usefulness, more increase the power of tonifying vital QI.
In the prescription of the present invention, Flos Lonicerae is sweet in flavor and cold in property, goes into lung stomach heart channel, and strong heat-clearing and toxic substances removing, diffusing carbuncle removing heat from blood effect are arranged; The Herba Selaginellae nature and flavor are hot flat, go into the liver spleen channel, the function heat-clearing and toxic substances removing, and blood circulation promoting and blood stasis dispelling, the dampness removing eliminating stagnation has the effect of eliminating stasis to stop pain; The little hardship of Herba Lobeliae Chinensis slightly sweet flavor cold in nature has heat-clearing and toxic substances removing, and is inducing diuresis and reducing edema, blood circulation invigorating efficacies; The Rhizoma Smilacis Glabrae slightly sweet flavor is flat, goes into liver stomach warp, and the effect in heat-clearing and toxic substances removing, dehumidifying, sharp joint is arranged; Herba Dracocephali acrid in the mouth cold nature, function heat-clearing and toxic substances removing, and the saturating network blood circulation promoting and dispersing pathogen accumulation of hot virtue.Above Flos Lonicerae, Herba Selaginellae, Herba Lobeliae Chinensis, Rhizoma Smilacis Glabrae, Herba Dracocephali are all had heat-clearing and toxic substances removing, an eliminating carbuncle mass-dissipating efficacy, are combined as usefulness, more increase the power that heat-clearing and toxic substances removing is driven away pathogenic factor.
In the prescription of the present invention, Radix Notoginseng sweet and slightly bitter taste warm in nature is gone into liver stomach warp, has the function of blood circulation promoting and blood stasis dispelling, alleviating pain and detumescence; The Herba Artemisiae Anomalae bitter in the mouth is warm in nature, goes into the conscience spleen channel, and the function removing blood stasis stimulates the menstrual flow, the relieving distension pain relieving, is the high product of blood circulation promoting and blood stasis dispelling; Sargassum bitter in the mouth cold in nature is salty, goes into liver stomach kidney channel, and the diffusing goiter effect of the knot that disappears is arranged; The Thallus Laminariae (Thallus Eckloniae) salty in the mouth is cold in nature, goes into the Liver and kidney warp, and removing heat-phlegm, hard masses softening and resolving effect are arranged, and is apt to separate the goiter sucutaneous nodule, with the same usefulness of Sargassum, renders a service stronger; The sweet slightly warm in nature of Fructus Crataegi sour in the mouth is gone into the taste Liver Channel, and long-pending, the stagnant effect of dissipating blood stasis that helps digestion is arranged, and is apt to into the capable knot of blood system blood stasis dispelling dissipating depression of QI; Radix Paeoniae Rubra bitter in the mouth cold nature is gone into Liver Channel, has removing heat from blood and promoting blood circulation, blood stasis slaking and dissipating edema analgesic effect; Rhizoma Corydalis bitter in the mouth suffering warm in nature is gone into liver spleen heart channel, invigorates blood circulation, promoting the circulation of QI, pain-relieving functions, is pain relieving good medicine; Olibanum bitter in the mouth suffering warm in nature is gone into the conscience spleen channel, invigorates blood circulation, pain relieving, stretches the muscle effect; Do not have the flat bitter in the mouth suffering of the property of medicine, go into liver heart spleen channel, the eliminating stasis to stop pain effect is arranged.Above Radix Notoginseng, Herba Artemisiae Anomalae, Sargassum, Thallus Laminariae (Thallus Eckloniae), Fructus Crataegi mutually 5 and usefulness has extremely strong blood circulation promoting and blood stasis dispelling, removing heat-phlegm, hard masses softening and resolving effect; If be equipped with Radix Paeoniae Rubra, Rhizoma Corydalis, Olibanum, Myrrha again, then more strengthen its promoting the circulation of QI and blood analgesic function.
In the prescription of the present invention, the Hepar Bovis seu Bubali sweet in the mouth is warm in nature, and the effect of tonifying liver benefit blood is arranged; Very light blue acrid in the mouth is warm in nature, goes into lung stomach warp, delivers the detoxicating functions that activates yang.Hepar Bovis seu Bubali and very light blue be the guiding drug of complete side, the Hepar Bovis seu Bubali priming is gone into blood system, very light blue logical battalion defends with the mediation the exterior and the interior.
Make a general survey of prescription of the present invention, strengthening vital QI to eliminate pathogenic factors, reinforcement and elimination in combination, adjusting negative and positive, specimen are all controlled, integrate tonifying vital QI, heat-clearing and toxic substances removing, dredge the meridian passage, blood circulation promoting and blood stasis dispelling, expectorant, hard masses softening and resolving, promoting the circulation of QI pain relieving, and by clinical verification, can be widely used in various carninomatosis patients' treatment, reach and suppress and elimination cancer remarkable result.
The specific embodiment
The present invention suppresses and eliminates the medicine of cancer, is to be made by the crude drug of following weight ratio:
Radix Notoginseng 3g Radix Astragali 6g Herba Dracocephali 4g Herba Artemisiae Anomalae 4g Sargassum 6g Thallus Laminariae (Thallus Eckloniae) 5g
Fructus Psoraleae 5g Herba Selaginellae 5g Herba Lobeliae Chinensis 5g Flos Lonicerae 5g Rhizoma Smilacis Glabrae 4g Hepar Bovis seu Bubali 6g
The very light blue 2g of Placenta Hominis 4g Cordyceps 3g Fructus Crataegi 5g.
The present invention suppresses and eliminates the medicine of cancer, can also be made by the crude drug of following weight ratio:
Radix Notoginseng 9g Radix Astragali 10g Herba Dracocephali 9g Herba Artemisiae Anomalae 9g Sargassum 10g Thallus Laminariae (Thallus Eckloniae) 10g
Fructus Psoraleae 10g Herba Selaginellae 8g Herba Lobeliae Chinensis 10g Flos Lonicerae 10g Rhizoma Smilacis Glabrae 10g Hepar Bovis seu Bubali 15g
The very light blue 5g Radix Paeoniae Rubra of Placenta Hominis 6g Cordyceps 4g Fructus Crataegi 8g 8g Rhizoma Corydalis 8g
Olibanum 5g Myrrha 5g.
The present invention has carried out clinical trial to 48 routine cancer patients, wherein male 27 people, women 21 people, oldest 80 years old, 15 years old of age minimum.
The clinical trial that 48 routine cancer patients are done
Sex Age Nasopharyngeal carcinoma Pulmonary carcinoma Esophageal carcinoma Gastric cancer Oral cancer Primary hepatocarcinoma Cancer of pancreas Colorectal cancer Breast carcinoma Uterus carcinoma Bladder cancer Thyroid carcinoma Malignant lymphoma
The man The woman Greatly Little
??27 ??21 ??80 ??15 ??3 ??5 ??5 ??8 ??3 ??6 ??2 ??2 ??5 ??3 ??2 ??2 ??2
Observation of curative effect statistical table after the treatment
Produce effects Take a turn for the better Stable Total effective rate
Case Obvious effective rate Case Improvement rate Case Coefficient of stabilization
??28 ??58% ??18 ??38% ????2 ??4% ??100%
Model case:
Open mark, man, 80 years old age.
Primary symptom: the gastral cavilty twinge, lump tenderness under the heart is fixed and is not moved.Body is very thin, spiritlessness and weakness, and the vomiting sputum, is had blood in stool pale tongue, white and thin fur, deep,thready and forceless pulse at hematemesis.
The patient takes the medicament capsule according to the present invention's preparation, and every contains crude drug 0.37 gram, each 6-8 grain, every day three times.Three months is a course of treatment, is aided with local external application therapy simultaneously, cooperates to treat.
Local external application therapy: the thing smalls of getting it filled stirs evenly and becomes pasty state, is affixed on the lump place of abdominal part mild tenderness.Change dressings once every day.
Curative effect: after treating for 1 week, patient's twinge disappears, and blood ends, and sputum reduces, can suitably take food, and produce effects after three months, patient's mental status is good, follows up a case by regular visits to not recurrence in 3 years.
The medicine of the present invention's preparation experimentizes to the nude mice of transplanting the Human Gastric Cancer cell, and the result shows that medicine has obvious suppression cancerous protuberance growth effect, does not influence nude mice body weight normal growth, no overt toxicity.
The present invention suppresses and the medicine of elimination cancer is to be prepared into powder, tablet, granule, pill, capsule or oral liquid according to known method in the pharmaceuticals industry.Also can be used as liniment uses.
The present invention can be adapted to various cancers and old, surgical contraindication is arranged and can not tolerate put, the treatment of patients undergoing chemotherapy, suppress to eliminate various cancers, can eliminate the various pain that cancer causes, improve patient's body recovery and life quality greatly.

Claims (5)

1, a kind of medicine that suppresses and eliminate cancer is characterized in that it mainly being that crude drug by following weight ratio is prepared from:
Radix Notoginseng 3-9g Radix Astragali 5-12g Herba Dracocephali 3-9g Herba Artemisiae Anomalae 3-9g Sargassum 5-15g
Thallus Laminariae (Thallus Eckloniae) 5-15g Fructus Psoraleae 5-15g Herba Selaginellae 3-9g Herba Lobeliae Chinensis 3-12g Flos Lonicerae 3-12g
Rhizoma Smilacis Glabrae 3-12g Hepar Bovis seu Bubali 6-20g Placenta Hominis 3-12g Cordyceps 3-8g Fructus Crataegi 3-9g
Very light blue 3-9g.
2, the medicine of inhibition according to claim 1 and elimination cancer is characterized in that can also adding in the said medicine Radix Paeoniae Rubra 0-12g, Rhizoma Corydalis 0-15g, Olibanum 0-9g, Myrrha 0-9g.
3, the medicine of inhibition according to claim 1 and elimination cancer is characterized in that it is to be made by the crude drug of following weight ratio:
Radix Notoginseng 3g Radix Astragali 6g Herba Dracocephali 4g Herba Artemisiae Anomalae 4g Sargassum 6g Thallus Laminariae (Thallus Eckloniae) 5g
Fructus Psoraleae 5g Herba Selaginellae 5g Herba Lobeliae Chinensis 5g Flos Lonicerae 5g Rhizoma Smilacis Glabrae 4g Hepar Bovis seu Bubali 6g
The very light blue 2g of Placenta Hominis 4g Cordyceps 3g Fructus Crataegi 5g.
4, the medicine of inhibition according to claim 1 and elimination cancer is characterized in that it is to be made by the crude drug of following weight ratio:
Radix Notoginseng 9g Radix Astragali 10g Herba Dracocephali 9g Herba Artemisiae Anomalae 9g Sargassum 10g Thallus Laminariae (Thallus Eckloniae) 10g
Fructus Psoraleae 10g Herba Selaginellae 8g Herba Lobeliae Chinensis 10g Flos Lonicerae 10g Rhizoma Smilacis Glabrae 10g Hepar Bovis seu Bubali 15g
The very light blue 5g Radix Paeoniae Rubra of Placenta Hominis 6g Cordyceps 4g Fructus Crataegi 8g 8g Rhizoma Corydalis 8g
Olibanum 5g Myrrha 5g.
5, the medicine of inhibition according to claim 1 and elimination cancer, the active component that it is characterized in that said medicine can become pharmaceutical composition with pharmaceutically acceptable vehicle group, makes powder, tablet, granule, electuary, pill, capsule and oral liquid.
CNB200510012306XA 2005-01-05 2005-01-05 Medicine for inhibiting and eliminating cancer Active CN1314409C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB200510012306XA CN1314409C (en) 2005-01-05 2005-01-05 Medicine for inhibiting and eliminating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB200510012306XA CN1314409C (en) 2005-01-05 2005-01-05 Medicine for inhibiting and eliminating cancer

Publications (2)

Publication Number Publication Date
CN1679889A true CN1679889A (en) 2005-10-12
CN1314409C CN1314409C (en) 2007-05-09

Family

ID=35066895

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB200510012306XA Active CN1314409C (en) 2005-01-05 2005-01-05 Medicine for inhibiting and eliminating cancer

Country Status (1)

Country Link
CN (1) CN1314409C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101279040B (en) * 2008-05-05 2011-07-20 王金贵 Chinese medicinal active anti-cancer vaccine and method of preparing the same
CN103083612A (en) * 2011-11-07 2013-05-08 陕西方舟制药有限公司 Traditional Chinese medicinal composition for treating cancers, and its preparation method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1150928C (en) * 2001-06-21 2004-05-26 焦成玉 Medicine for curing cancers and its preparation method
CN1265833C (en) * 2003-12-30 2006-07-26 杨庆甲 Chinese medicinal preparation for treating cancer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101279040B (en) * 2008-05-05 2011-07-20 王金贵 Chinese medicinal active anti-cancer vaccine and method of preparing the same
CN103083612A (en) * 2011-11-07 2013-05-08 陕西方舟制药有限公司 Traditional Chinese medicinal composition for treating cancers, and its preparation method

Also Published As

Publication number Publication date
CN1314409C (en) 2007-05-09

Similar Documents

Publication Publication Date Title
CN1899500A (en) Acne clearing decoction
CN104147534A (en) Traditional Chinese medicine composition for treating various cancers
CN103041277B (en) Traditional Chinese medicine for treating peptic ulcer
CN1265833C (en) Chinese medicinal preparation for treating cancer
CN101032593A (en) Acne-treating Chinese medicine preparation
CN105708901A (en) Foot-bath medicine for treating turbid toxin accumulation type chronic atrophic gastritis and preparation method of foot-bath medicine
CN1943754A (en) A Medicine for treatment of gastrointestinal diseases
CN102343079A (en) Traditional Chinese medicine for treating cancerous fever of liver and gallbladder damp-heat type
CN101856481A (en) Externally used ointment for dispersing swelling and dissipating binds
CN103751290B (en) One treats psoriatic pharmaceutical composition
CN103432486B (en) Traditional Chinese medicine composition for treating leukoplakia vulvae
CN102755515B (en) Traditional Chinese medicine decoction for treating hyperplasia of mammary glands
CN1314409C (en) Medicine for inhibiting and eliminating cancer
CN102028831B (en) Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof
CN1186083C (en) Chinese medicine for treating mammary gland foliole proliferation
CN104288597A (en) Traditional Chinese medicine composition for treating herpes zoster
CN105233230A (en) Traditional Chinese medicine for treating duodenal stasis
CN1943766A (en) A Chinese traditional medicinal preparation for treatment of psoriasis
CN1202859C (en) Chinese medicine for treating protrasion of the lumber intervertebral disci
CN1843492A (en) Traditional Chinese medicine preparation for treating mammary gland hyperplasia
CN104056053A (en) Traditional Chinese medicine preparation for treating non-purulent costal chondritis
CN103479960A (en) Chronic Hepatitis B disease treatment Chinese herbal
CN101028352A (en) Chinese-medicinal preparation for treating ischiodynia
CN106109944A (en) A kind of Chinese medicine composition treating oral ulcer
CN101028421A (en) Chinese medicine for treating chronic kidney failure

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant